BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11745245)

  • 21. Detection of clonal T-cell receptor gamma gene rearrangements with the use of the polymerase chain reaction in cutaneous lesions of mycosis fungoides and Sézary syndrome.
    Bachelez H; Bioul L; Flageul B; Baccard M; Moulonguet-Michau I; Verola O; Morel P; Dubertret L; Sigaux F
    Arch Dermatol; 1995 Sep; 131(9):1027-31. PubMed ID: 7661604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytologic evaluation of lymphadenopathy associated with mycosis fungoides and Sezary syndrome: role of immunophenotypic and molecular ancillary studies.
    Pai RK; Mullins FM; Kim YH; Kong CS
    Cancer; 2008 Oct; 114(5):323-32. PubMed ID: 18798522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cutaneous histopathology of Sézary syndrome: a study of 41 cases with a proven circulating T-cell clone.
    Trotter MJ; Whittaker SJ; Orchard GE; Smith NP
    J Cutan Pathol; 1997 May; 24(5):286-91. PubMed ID: 9194581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of clonally rearranged T-cell-receptor gamma chain genes from T-cell malignancies and acute inflammatory rheumatic disease using PCR amplification, PAGE, and automated analysis.
    Witzens M; Möhler T; Willhauck M; Scheibenbogen C; Lee KH; Keilholz U
    Ann Hematol; 1997 Mar; 74(3):123-30. PubMed ID: 9111425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complete molecular remission during biologic response modifier therapy for Sézary syndrome is associated with enhanced helper T type 1 cytokine production and natural killer cell activity.
    Yoo EK; Cassin M; Lessin SR; Rook AH
    J Am Acad Dermatol; 2001 Aug; 45(2):208-16. PubMed ID: 11464181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Detection of clonal T-cell receptor gamma gene rearrangement with the use of PCR-DGGE for diagnosis of erythroderma].
    Cordel N; Lenormand B; Courville P; Lauret P; Joly P
    Ann Dermatol Venereol; 2001 Mar; 128(3 Pt 1):220-3. PubMed ID: 11319384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peripheral blood findings in erythrodermic patients: importance for the differential diagnosis of Sézary syndrome.
    Nagler AR; Samimi S; Schaffer A; Vittorio CC; Kim EJ; Rook AH
    J Am Acad Dermatol; 2012 Mar; 66(3):503-8. PubMed ID: 22005074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of clonal T-cell receptor gene rearrangements in the peripheral blood of patients with mycosis fungoides/Sezary syndrome.
    Weiss LM; Wood GS; Hu E; Abel EA; Hoppe RT; Sklar J
    J Invest Dermatol; 1989 Apr; 92(4):601-4. PubMed ID: 2784818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paucity of FOXP3+ cells in skin and peripheral blood distinguishes Sézary syndrome from other cutaneous T-cell lymphomas.
    Klemke CD; Fritzsching B; Franz B; Kleinmann EV; Oberle N; Poenitz N; Sykora J; Banham AH; Roncador G; Kuhn A; Goerdt S; Krammer PH; Suri-Payer E
    Leukemia; 2006 Jun; 20(6):1123-9. PubMed ID: 16557241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Analyses of the rearrangement of T-cell receptor- and immunoglobulin genes in the diagnosis of lymphoproliferative disorders].
    Griesser DH
    Veroff Pathol; 1995; 144():1-109. PubMed ID: 7856305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sezary syndrome: cutaneous immunoperoxidase double-labeling technique demonstrates CD4/CD8 ratio non-specificity.
    Balfour EM; Glusac EJ; Heald P; Talley LL; Smoller BR
    J Cutan Pathol; 2003 Aug; 30(7):437-42. PubMed ID: 12859741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene Expression Comparison between Sézary Syndrome and Lymphocytic-Variant Hypereosinophilic Syndrome Refines Biomarkers for Sézary Syndrome.
    Moerman-Herzog A; Mehdi SJ; Wong HK
    Cells; 2020 Aug; 9(9):. PubMed ID: 32872487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The clinical characteristics of autoimmune haemolytic anaemia/Evans syndrome patients with clonal immunoglobulin/T cell receptor gene rearrangement.
    Zhu H; Zhao M; Cao Z; Yang J; Li Y; Xing L
    Autoimmunity; 2020 Nov; 53(7):394-399. PubMed ID: 32924630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Flow cytometric DNA ploidy analysis of peripheral blood from patients with sezary syndrome: detection of aneuploid neoplastic T cells in the blood is associated with large cell transformation in tissue.
    Wang S; Li N; Heald P; Fisk JM; Fadare O; Howe JG; McNiff JM; Smith BR
    Am J Clin Pathol; 2004 Nov; 122(5):774-82. PubMed ID: 15491974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frequency and prognostic significance of clonal T-cell receptor beta-gene rearrangements in the peripheral blood of patients with mycosis fungoides.
    Bakels V; van Oostveen JW; Gordijn RL; Walboomers JM; Meijer CJ; Willemze R
    Arch Dermatol; 1992 Dec; 128(12):1602-7. PubMed ID: 1456753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TCRgamma-chain gene rearrangement by GeneScan: incidence and significance of clonal heterogeneity in Sézary syndrome.
    Fierro MT; Ponti R; Titli S; Bonello L; Comessatti A; Novelli M; Fava P; di Celle PF; Quaglino P; Bernengo MG
    J Invest Dermatol; 2010 Sep; 130(9):2312-9. PubMed ID: 20410915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of c-myb in leukaemic and non-leukaemic variants of cutaneous T-cell lymphoma.
    Poenitz N; Simon-Ackermann J; Gratchev A; Qadoumi M; Klemke CD; Stadler R; Kremer A; Radenhausen M; Henke U; Assaf C; Utikal J; Goerdt S; Dippel E
    Dermatology; 2005; 211(2):84-92. PubMed ID: 16088151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Xenograft and cell culture models of Sézary syndrome reveal cell of origin diversity and subclonal heterogeneity.
    Poglio S; Prochazkova-Carlotti M; Cherrier F; Gros A; Laharanne E; Pham-Ledard A; Beylot-Barry M; Merlio JP
    Leukemia; 2021 Jun; 35(6):1696-1709. PubMed ID: 33106625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sézary syndrome without erythroderma: A review of 16 cases at Mayo Clinic.
    Thompson AK; Killian JM; Weaver AL; Pittelkow MR; Davis MD
    J Am Acad Dermatol; 2017 Apr; 76(4):683-688. PubMed ID: 28012574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of 9-O-acetylated ganglioside D3 (CD60) and {alpha}4{beta}1 (CD49d) expression in predicting the survival of patients with Sezary syndrome.
    Scala E; Abeni D; Pomponi D; Narducci MG; Lombardo GA; Mari A; Frontani M; Picchio MC; Pilla MA; Caprini E; Russo G
    Haematologica; 2010 Nov; 95(11):1905-12. PubMed ID: 20663947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.